Marc P Bonaca
Overview
Explore the profile of Marc P Bonaca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
260
Citations
9111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scimeca G, Krishnathasan D, Rashedi S, Lan Z, Sato A, Hamade N, et al.
J Thromb Thrombolysis
. 2025 Mar;
PMID: 40064840
COVID-19 is associated with an increased risk of venous thromboembolism (VTE) in hospitalized patients. Although prior studies have attempted to identify predictors of VTE, restricted sample size and use of...
2.
Bonaca M, Lang N, Chen A, Amiri-Kordestani L, Lipka L, Zwiewka M, et al.
JACC CardioOncol
. 2025 Feb;
7(2):83-95.
PMID: 39967209
The development of novel treatments has improved cancer outcomes but may result in cardiovascular toxicities. Traditional approaches to clinical trial safety evaluation have limitations in their ability to detect signals...
3.
Saldarriaga C, Zannad F, McMullan C, Xing A, Gates D, Anstrom K, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 39956649
Aims: To describe the baseline characteristics of the participants in the VICTOR (Vericiguat Global Study in Patients with Chronic Heart Failure; NCT05093933) trial and compare them to recent trials in...
4.
Rashedi S, Keykhaei M, Sato A, Steg P, Piazza G, Eikelboom J, et al.
J Am Coll Cardiol
. 2025 Feb;
PMID: 39918465
Background: The optimal long-term antithrombotic strategy in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) remains uncertain. Individual randomized controlled trials (RCTs) had variations in their reported...
5.
Divakaran S, Harms H, Robertson M, Merugumala S, Park M, Kijewski M, et al.
J Nucl Cardiol
. 2025 Jan;
:102143.
PMID: 39889951
Background: The pathophysiology of symptoms and reduced exercise capacity from peripheral artery disease (PAD) remains unclear. Additionally, there is limited information on blood flow and skeletal muscle energetics after walking...
6.
Hess C, Daffron A, Nehler M, Szarek M, Cannon C, Hsia J, et al.
Vasc Med
. 2025 Jan;
1358863X241309839.
PMID: 39868915
No abstract available.
7.
Canonico M, Bauersachs R, Bonaca M
J Am Coll Cardiol
. 2025 Jan;
85(3):e45-e46.
PMID: 39843038
No abstract available.
8.
Naveh S, Rogers R, Hess C, Nehler M, Hsia J, Bonaca M
JACC Case Rep
. 2024 Dec;
29(23):102717.
PMID: 39691331
Patients with chronic limb threatening ischemia are at high risk for cardiovascular events, mortality, and adverse limb events. A 62-year-old man with diabetes and peripheral artery disease presented with a...
9.
Gluckman T, Chiu S, Rider D, Tseng P, Tseng P, Mudd J, et al.
Clin Cardiol
. 2024 Dec;
47(12):e70055.
PMID: 39686565
Introduction: While left ventricular ejection fraction (LVEF) represents an important means by which to classify patients with heart failure (HF), relatively little is known about the distribution of LVEFs among...
10.
Lakkireddy D, Angiolillo D, Charlton-Ouw K, Jefferson B, Peeran S, Bisharat M, et al.
Clin Cardiol
. 2024 Dec;
47(12):e70039.
PMID: 39663755
Introduction: Coronary artery disease (CAD) and peripheral artery disease (PAD) increase the risks of cardiovascular events and death. Digital health technologies are rapidly expanding to improve healthcare quality and access....